Location & Dates: Champalimaud Foundation, 24 June to 3 July
Application deadline: 26 May
Acceptance notification: 31 May
Cost: €200. The fee covers the course, meals and accommodation. Please note that the payment should be completed by 7 June.
Capacity: 30 Students
Please note that registration deadline for this course has now passed.
Description:
The First International Portugal-USA Summer Course in Cancer Research will take place from 24 June to 3 July 2024 at the Champalimaud Foundation (Lisbon, Portugal). A premier non-profit cancer research and care institution in Portugal, the Champalimaud Foundation is renowned for its commitment to advancing scientific knowledge in cancer, physiology, and neuroscience through initiatives such as the Champalimaud Research educational programme, established in 2017. This programme brings together leading researchers from around the globe to impart cutting-edge scientific insights to the next generation of scholars.
Goals:
The primary objective of the Cancer Summer Course is to offer graduate students and postdoctoral fellows from Portugal and beyond a comprehensive and interactive learning experience in cancer research, while also nurturing critical thinking and soft skills development. The curriculum encompasses both fundamental and advanced topics in cancer biology, including the history of cancer, oncogenes and tumor suppressor genes, tumor microenvironment, mechanisms of therapy resistance, cancer cell plasticity, epigenetics, and cancer metabolism. Moreover, the course incorporates career development sessions focusing on grant writing, science communication, career alternatives, and ample opportunities for interaction with leading faculty members in the field of cancer research, along with recreational activities to facilitate informal networking.
This summer course is a key component of the PT-USA Cancer Initiative, that aims to facilitate trans-Atlantic research collaborations among faculty members from 20 premier academic institutions in the USA and in Portugal. It provides valuable educational opportunities for graduate students and postdoctoral fellows, the course serves as a platform for USA/PT investigators to identify top Portuguese/American trainees for potential sabbatical placements in their laboratories, fostering collaborative research projects between USA and Portuguese faculty members.
Programme at a glance here.
Selection criteria:
PhD students, Physician-Scientists and early career postdocs (<2 years PhD defence) working on cancer biology and/or biomedicine are encouraged to apply through this form.
Selection committee:
Adriana Sánchez Danés, Champalimaud Foundation
Joseph Kissil, Moffitt Cancer Center
Joana Paredes, Instituto de Investigação e Inovação em Saúde da Universidade do Porto
Mónica Bettencourt-Dias, Instituto Gulbenkian de Ciência
Ronald de Pinho, MD Anderson Cancer Center, University of Texas
Carmen Jerónimo, Instituto Português de Oncologia do Porto, Francisco Gentil, EPE
Sérgio Dias, Instituto de Medicina Molecular
Joao Conde, NOVA Medical School
Pedro Castelo-Branco, Algarve Biomedical Center Research Institute
Faculty
United States
Ronald de Pinho, MD Anderson Cancer Center, University of Texas
Joseph Kissil, Moffitt Cancer Center
Tannishtha Reya, Columbia University
Robert Wechsler-Reya, Columbia University
Martin McMahon, University of Utah
Katerina Politi, Yale School of Medicine
Andrea Ventura, Sloan Kettering Institute
Kevin Haigis, Dana-Farber Cancer Institute
Michelina Janiszewska, The Herbert Wertheim UF Scripps Institute
Portugal
Adriana Sánchez-Danés, Champalimaud Foundation
Mónica Bettencourt-Dias, Instituto Gulbenkian de Ciência
Joana Paredes, Instituto de Investigação e Inovação em Saúde da Universidade do Porto
Bruno Silva-Santos, Instituto de Medicina Molecular
Henrique Veiga-Fernandes, Champalimaud Foundation
Joao Barata, Instituto de Medicina Molecular
Paulo Oliveira, Center for Neuroscience and Cell Biology
Jose Machado, Instituto de Investigação e Inovação em Saúde da Universidade do Porto
Carmen Jerónimo, Instituto Português de Oncologia do Porto, Francisco Gentil, EPE
Carlos Minutti, Champalimaud Foundation
Jorge Lima, Instituto de Patologia e Imunologia Molecular da Universidade do Porto
Belgium
Jean Christophe-Marine, KU Leuven
Organisers:
Adriana Sánchez-Danés, Champalimaud Foundation
Joseph Kissil, Moffitt Cancer Center
Contact for General Enquiries
For general enquiries, please contact cancer_course2024@research.fchampalimaud.org
This course is sponsored by the generous support of:
Teresa and Jose Ivo
Nina and Lisa Lesavoy
Ronald A. DePinho
Dewey Stringer and Adopt-A-Scientist Cure Cancer Foundation
Champalimaud Foundation
